We also show that central Nav1.8 channels can be targeted pharmacologically to improve chemoreceptor function in Tcf4tr/+ mice, establishing Nav1.8 as a high priority target with therapeutic potential in PTHS. The gene discussed is SCN10A; the disease is Pitt-Hopkins syndrome.